Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Shares of Avadel Are Sinking Today

TheMotleyFool

0 0

Why Shares of Avadel Are Sinking TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) are down 14% as of 1:29 p.m. EDT today after the Food and Drug Administration said it would need more time than originally thought to review FT218 -- Avadel's candidate to treat narcolepsy.

After accepting a company's approval filing, the FDA provides applicants with a date known as the Prescription Drug User Fee Amendments date -- or PDUFA date. It's intended to give drugmakers insight into the review timeline.

Image source: Getty Images.

Source Fool.com

Like: 0

AVDL

Teilen